Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6031 to 6045 of 7682 results

  1. Same-day hospital specialist assessment: Which people with extreme hypertension (220/120 mmHg or higher) or emergency symptoms should be referred for same-day hospital specialist assessment?

    Recommendation ID NG136/06 Question Same-day hospital specialist assessment: Which people with extreme hypertension (220/120 mmHg or higher)

  2. Primary care-led assessment models:- Which primary care-led models of assessment of people with a suspected medical emergency in the community, such as GP home visits, are most clinically and cost effective? [See the evidence review on GP-led home visits.]

    Recommendation ID NG94/8 Question Primary care-led assessment models:- Which primary care-led models of assessment of people with a suspected

  3. Signs and symptoms of Kawasaki disease: Which signs and symptoms (or combinations of signs and symptoms) predict a diagnosis of Kawasaki disease in children under 5 presenting with fever lasting 5 days or more?

    Recommendation ID NG143/08 Question Signs and symptoms of Kawasaki disease: Which signs and symptoms (or combinations of signs and symptoms)

  4. What is the effectiveness, cost effectiveness and acceptability of the whole family approach to carers' assessments?

    Recommendation ID NG150/1 Question What is the effectiveness, cost effectiveness and acceptability of the whole family approach to carers'

  5. What is the efficacy and cost effectiveness of rehabilitation services compared with treatment as usual for people with complex psychosis with residual disability, who are leaving early intervention services?

    Recommendation ID NG181/1 Question What is the efficacy and cost effectiveness of rehabilitation services compared with treatment as usual

  6. Holistic assessment in the community:- What is the clinical and cost effectiveness of a community holistic assessment and intervention for people living with high levels of multimorbidity?

    Recommendation ID NG56/2 Question Holistic assessment in the community:- What is the clinical and cost effectiveness of a community holistic

  7. What is the effectiveness and cost effectiveness of different scheduling of zoledronic acid in the prevention and reduction of skeletal events in people with hormone-refractory prostate cancer?

    Recommendation ID NG131/8 Question What is the effectiveness and cost effectiveness of different scheduling of zoledronic acid in the prevention

  8. Biological therapies for peripheral spondyloarthritis:- What is the effectiveness and cost effectiveness of biological DMARDs in people with persistent peripheral spondyloarthritis (excluding psoriatic arthritis) or undifferentiated spondyloarthritis?

    Recommendation ID NG65/5 Question Biological therapies for peripheral spondyloarthritis:- What is the effectiveness and cost effectiveness

  9. Tests to diagnose paroxysmal atrial fibrillation: What is the diagnostic accuracy of key index tests compared with the gold standard of prolonged ambulatory monitoring in people suspected of having paroxysmal atrial fibrillation?

    Recommendation ID NG196/2 Question Tests to diagnose paroxysmal atrial fibrillation: What is the diagnostic accuracy of key index tests

  10. Models of care and support at home:- What is the effectiveness and cost effectiveness of care and support models (for example, assistive technology) for people growing older with learning disabilities to enable them to live in the family home?

    Recommendation ID NG96/1 Question Models of care and support at home:- What is the effectiveness and cost effectiveness of care and support

  11. Continuous glucose monitoring in children and young people with type 2 diabetes: What is the effectiveness and cost effectiveness of continuous glucose monitoring devices in children and young people with type 2 diabetes?

    Recommendation ID NG18/01 Question Continuous glucose monitoring in children and young people with type 2 diabetes: What is the effectiveness

  12. Staging investigations for CPG 3 prostate cancer: What is the diagnostic accuracy of staging investigations for CPG 3 prostate cancer?

    Recommendation ID NG131/6 Question Staging investigations for CPG 3 prostate cancer: What is the diagnostic accuracy of staging investigations